雜志介紹

Molecular Carcinogenesis雜志介紹

《Molecular Carcinogenesis》是(shi)一本以(yi)English為主(zhu)的(de)未開放(fang)獲取國際優秀期刊(kan)，中文名稱分子致癌(ai)，本刊(kan)主(zhu)要出版、報(bao)道醫學(xue)-BIOCHEMISTRY & MOLECULAR BIOLOGY領域(yu)的(de)研究動態以(yi)及(ji)在該(gai)領域(yu)取得的(de)各方面的(de)經(jing)驗和(he)(he)科研成果(guo)，介紹該(gai)領域(yu)有(you)關本專業(ye)的(de)最新進展(zhan)，探討行業(ye)發(fa)展(zhan)的(de)思路和(he)(he)方法，以(yi)促進學(xue)術信息交(jiao)流，提(ti)高行業(ye)發(fa)展(zhan)。該(gai)刊(kan)已被國際權威(wei)數據庫SCIE收錄，為該(gai)領域(yu)相關學(xue)科的(de)發(fa)展(zhan)起到了(le)良(liang)好的(de)推(tui)動作(zuo)用，也得到了(le)本專業(ye)人員的(de)廣泛(fan)認可(ke)。該(gai)刊(kan)最新影響因(yin)子為3，最新CiteScore 指數為7.3。

本刊近期中(zhong)國學者發表的論文主要有：

• Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer

  Author: Yang, Xiao-Rong; Pi, Can; Zhang, Yi-Chen; Chen, Zhi-Hong; Zhang, Xu-Chao; Zhu, Dong-Qin; Yang, Ling-Ling; Yin, Jiani C. C.; Deng, Jia-Yi; Yang, Ming-Yi; Luo, Wei-Chi; Wu, Yi-Long; Zhou, Qing

• m7G-related genes-NCBP2 and EIF4E3 determine immune contexture in head and neck squamous cell carcinoma by regulating CCL4/CCL5 expression

  Author: Xu, Xuhui; Zhao, Yue; Ying, Yukang; Zhu, Haoran; Luo, Jun; Mou, Tingchen; Zhang, Zhenxing

• Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2-RCHY1 mediated signaling pathway

  Author: Wang, Xiwei; Zheng, Yingying; Chai, Zhengbin; Li, Ji; Zhu, Changhui; Peng, Yanling; Qiu, Juanjuan; Xu, Jiajun; Liu, Chunyan

• DDIT4 promotes malignancy of head and neck squamous cell carcinoma

  Author: Zhang, Zhenxing; Zhu, Haoran; Zhao, Chifeng; Liu, Dong; Luo, Jun; Ying, Yukang; Zhong, Yuan

英文介紹

Molecular Carcinogenesis雜志英文介紹

Molecular Carcinogenesis publishes articles describing discoveries in basic and clinical science of the mechanisms involved in chemical-, environmental-, physical (e.g., radiation, trauma)-, infection and inflammation-associated cancer development, basic mechanisms of cancer prevention and therapy, the function of oncogenes and tumors suppressors, and the role of biomarkers for cancer risk prediction, molecular diagnosis and prognosis.